Welcome to The Lancet on Twitter. Keep in touch with The Lancet, one of the world's leading general medical journals, published weekly since 1823.
10 million deaths in children aged under 5 years can be attributed to conflict from 1995-2015. However, evidence of how armed conflict indirectly affects women and children is sparse, write @ebdStanford et al. in @TheLancet ’s #WCHinConflict Series:
Multi-sectors and stakeholder groups have the responsibility to support women's and children's health in conflict setting; all actors must commit to greater alignment, investment and political attention, writes @HelenClarkUNDP : #WCHinConflict @PMNCH
"There are 3 areas are crying out for greater attention ", says @HelenClarkUNDP : 1⃣Gender-based interventions 2⃣Adolescent health and wellbeing 3⃣Early childhood development
Zulfiqar Bhutta et al. advocate for the creation of an independent technical advisory group to help steer efforts to improve health and nutrition action for women and children affected by conflict. Read: #WCHinConflict
For patients with rheumatoid #arthritis and low or absent B-cell lineage expression signature in synovial tissue, tocilizumab is more effective than rituximab, suggests the first biopsy-driven trial. Read the results in full:
Unclear why the HSE is still not recommending respirators as PPE for public-facing workers, Raymond Agius et al. write that the HSE must "step up...independently of political influence, & firmly enforce occupational hygiene measures for source control..."
Using 10 case studies of humanitarian health response in conflict, @neha_s_singh et al. reveal the prioritisation and delivery of lifesaving and essential interventions for conflict-affected women and children. Read: #WCHinConflict
Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet
NEW—UK’s #COVID19 vaccine is safe and induces an immune reaction, according to preliminary results
NEW Research—No evidence of benefit for #chloroquine and #hydroxychloroquine in #COVID19 patients, urgent randomised trials are needed: finding from a large observational study of nearly 15,000 patients with #COVID19 & 81,000 controls Thread (1/4)
NEW—Most comprehensive study to date provides evidence on optimal physical distancing, face masks, and eye protection to prevent spread of #COVID19 : a systematic review and meta-analysis of 172 observational studies
We have published an Expression of Concern on the paper by Mehra et al on hydroxychloroquine and chloroquine published on May 22, 2020